KalVista Pharmaceuticals's market cap is currently $562.32M. The company's EPS TTM is $-1.12; its P/E ratio is ―; KalVista Pharmaceuticals is scheduled to report earnings on September 11, 2025, and the estimated EPS forecast is $-1.03. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25
Dec 24
Dec 23
Dec 22
Dec 21
Currency in USD
KalVista Pharmaceuticals Earnings and Revenue History
